Legal & General Group’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1K Sell
951
-186
-16% -$3.16K ﹤0.01% 3041
2025
Q4
$21.3K Sell
1,137
-262
-19% -$3.96K ﹤0.01% 2997
2025
Q3
$17.9K Hold
1,399
﹤0.01% 3089
2025
Q2
$23.5K Sell
1,399
-3,903
-74% -$52.7K ﹤0.01% 2942
2025
Q1
$67.9K Sell
5,302
-14,146
-73% -$227K ﹤0.01% 2697
2024
Q4
$343K Sell
19,448
-5,845
-23% -$111K ﹤0.01% 2581
2024
Q3
$578K Buy
25,293
+2,116
+9% +$47.8K ﹤0.01% 2413
2024
Q2
$532K Buy
23,177
+6,525
+39% +$201K ﹤0.01% 2403
2024
Q1
$660K Buy
16,652
+3,130
+23% +$124K ﹤0.01% 2327
2023
Q4
$535K Buy
13,522
+306
+2% +$12.8K ﹤0.01% 2421
2023
Q3
$586K Buy
13,216
+1,478
+13% +$64.5K ﹤0.01% 2373
2023
Q2
$511K Buy
11,738
+5,073
+76% +$223K ﹤0.01% 2458
2023
Q1
$290K Buy
6,665
+566
+9% +$25K ﹤0.01% 2463
2022
Q4
$227K Sell
6,099
-40
-0.7% -$1.55K ﹤0.01% 2556
2022
Q3
$244K Buy
6,139
+542
+10% +$20.1K ﹤0.01% 2554
2022
Q2
$214K Buy
5,597
+492
+10% +$17.8K ﹤0.01% 2603
2022
Q1
$202K Sell
5,105
-11
-0.2% -$431 ﹤0.01% 2662
2021
Q4
$213K Buy
5,116
+25
+0.5% +$1.09K ﹤0.01% 2701
2021
Q3
$215K Buy
5,091
+2,735
+116% +$138K ﹤0.01% 2668
2021
Q2
$109K Sell
2,356
-94
-4% -$4.47K ﹤0.01% 2703
2021
Q1
$104K Buy
2,450
+471
+24% +$22.9K ﹤0.01% 2609
2020
Q4
$85K Sell
1,979
-34
-2% -$1.75K ﹤0.01% 2630
2020
Q3
$99K Sell
2,013
-603
-23% -$33.4K ﹤0.01% 2494
2020
Q2
$152K Buy
2,616
+281
+12% +$14.8K ﹤0.01% 2421
2020
Q1
$106K Sell
2,335
-527
-18% -$31.7K ﹤0.01% 2393
2019
Q4
$189K Buy
2,862
+464
+19% +$28.4K ﹤0.01% 2411
2019
Q3
$139K Hold
2,398
﹤0.01% 2435
2019
Q2
$139K Buy
2,398
+280
+13% +$13K ﹤0.01% 2438
2019
Q1
$82K Hold
2,118
﹤0.01% 2550
2018
Q4
$81K Buy
2,118
+549
+35% +$21.1K ﹤0.01% 2515
2018
Q3
$61K Hold
1,569
﹤0.01% 2681
2018
Q2
$59K Hold
1,569
﹤0.01% 2677
2018
Q1
$46K Hold
1,569
﹤0.01% 2791
2017
Q4
$59K Hold
1,569
﹤0.01% 2817
2017
Q3
$59K Buy
1,569
+281
+22% +$8.83K ﹤0.01% 2865
2017
Q2
$35K Hold
1,288
﹤0.01% 3002
2017
Q1
$25K Sell
1,288
-292
-18% -$5.4K ﹤0.01% 3023
2016
Q4
$30K Buy
+1,580
New +$26.1K ﹤0.01% 3026

Other funds holding NRC